Fresenius Medical Care AG & Co KGaA St (FME)

Index:

Xetra DAX

  35.91
   
  • Change Today:
     0.55
  • 52 Week High:  42.06
  • 52 Week Low:  31.49
  • Currency: Euro
  • Shares Issued: 293.00m
  • Volume: 411,717
  • Market Cap:  10,522m

Fundamentals - based on IFRS

    (Millions)   (Millions)   (Millions)   (Millions)   (Millions)
Income Statement 31-Dec-22 31-Dec-21 31-Dec-20 31-Dec-19 31-Dec-18
Continuing Operations          
Revenue 19,398.00 17,619.00 17,859.00 17,477.00 16,546.87
Operating Profit/(Loss) 1,512.00 1,852.00 2,399.00 2,344.00 3,111.14
Profit Before Tax 1,220.00 1,571.86 1,936.00 1,841.00 2,736.74
Profit After Tax 895.00 1,219.00 1,435.00 1,439.00 2,225.66
           
Earnings per Share - Basic 230.00¢ 3.34¢ 396.00¢ 396.00¢ 647.00¢
Earnings per Share - Adjusted 230.00¢ 3.34¢ 396.00¢ 396.00¢ 647.00¢
           
Dividend per Share 135.00¢ 1.36¢ 134.00¢ 120.00¢ 117.00¢
    (Millions)   (Millions)   (Millions)   (Millions)   (Millions)
Balance Sheet 31-Dec-22 31-Dec-21 31-Dec-20 31-Dec-19 31-Dec-18
Assets          
Non-Current Assets          
Property, Plant & Equipment 4,187.00 4,316.00 8,186.75 8,515.40 3,836.01
Intangible Assets 17,310.00 15,821.00 14,339.74 15,443.58 12,890.94
Other Non-Current Assets 8,203.00 7,967.00 1,887.24 1,810.61 1,668.44
  29,700.00 28,104.00 24,413.73 25,769.59 18,395.38
Current Assets          
Inventories n/a n/a 1,895.31 1,663.28 1,466.80
Cash at Bank & in Hand n/a n/a 1,081.54 1,007.72 2,145.63
Other Current Assets 6,054.00 6,263.00 4,298.46 4,494.15 4,234.45
  6,054.00 6,263.00 7,275.31 7,165.15 7,846.89
           
Other Assets n/a n/a n/a n/a n/a
Total Assets 35,754.00 34,367.00 31,689.04 32,934.73 26,242.27
Current Liabilities          
Borrowings 6,467.00 7,258.00 1,696.79 3,257.83 2,500.71
Other Current Liabilities n/a n/a 4,462.86 3,801.23 3,767.57
           
Current Liabilities 6,467.00 7,258.00 6,159.65 7,059.06 6,268.28
           
Net Current Assets c(413.00) c(995.00) c1,115.66 c106.08 c1,578.60
           
Borrowings 13,838.00 13,130.00 10,683.23 10,524.62 5,045.52
Other Non-Current Liabilities n/a n/a 2,514.85 2,123.82 2,026.51
Non-Current Liabilities 13,838.00 13,130.00 13,198.08 12,648.43 7,072.03
           
Other Liabilities n/a n/a n/a n/a n/a
Total Liabilities 20,305.00 20,388.00 19,357.73 19,707.50 13,340.31
           
Net Assets 15,449.00 13,979.00 12,331.31 13,227.24 12,901.96
           
Shareholders Funds 15,449.00 13,979.00 11,215.08 11,957.91 11,758.41
           
Minority Interests/Other Equity n/a n/a 1,116.23 1,269.32 1,143.55
Total Equity 15,449.00 13,979.00 12,331.31 13,227.24 12,901.96
Cash Flow 31-Dec-22 31-Dec-21 31-Dec-20 31-Dec-19 31-Dec-18
Net Cash Flow From Operating Activities n/a n/a 4,233.16 2,566.95 2,061.91
Net Cash Flow from Investing Activities n/a n/a (1,334.94) (3,285.99) (245.04)
Net Cash Flow from Financing Activities n/a n/a (2,824.40) (418.87) (649.35)
Net Increase/Decrease In Cash n/a n/a 73.82 (1,137.91) 1,167.52
Ratios - based on IFRS 31-Dec-22 31-Dec-21 31-Dec-20 31-Dec-19 31-Dec-18
Continuing Operations          
PE Ratio - Adjusted 13.3 1,710.2 17.2 16.7 8.8
PEG - Adjusted 0.0 n/a n/a n/a 0.2
Earnings per Share Growth - Adjusted 6,784% -99% n/a -39% 55%
Dividend Cover 1.70 2.45 2.96 3.30 5.53
Revenue per Share 6,620.48¢ 60.70¢ 6,095.22¢ 5,964.85¢ 5,647.40¢
Pre-Tax Profit per Share 416.38¢ 5.42¢ 660.75¢ 628.33¢ 934.04¢
Operating Margin 7.79% 10.51% 13.43% 13.41% 18.80%
Return on Capital Employed 6.61% 0.09% 18.67% 15.92% 36.21%
           
Dividend Yield 4.4% 0.0% 2.0% 1.8% 2.1%
Dividend per Share Growth 9,806.85% (98.98%) 11.67% 2.56% 10.38%
Operating Cash Flow per Share n/a n/a 1,444.77¢ 876.09¢ 703.72¢
Cash Incr/Decr per Share n/a n/a 25.20¢ (388.37¢) 398.47¢
Net Asset Value per Share (exc. Intangibles) (635.15¢) (628.67¢) (685.47¢) (756.43¢) 3.76¢
Net Gearing 131.43% 145.85% 100.74% 106.83% 45.93%

Key

* GAAP

a. Includes discontinued activities

b. Including assets due in more than one year

c. Not disclosed under IFRS

d. Total fixed assets

e. Includes borrowings

f. Included in cash flow from operating activities under IFRS

g. Included in net cash from investing activities under IFRS

h. Pre-tax

i. Capital expenditure

j. Based on operating cash flow before tax

k. Issue of ordinary shares

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Forecast figures based on normalised accounts.

 

Top of Page